Trial Information

Summary: Unverricht-Lundborg Disease (ULD), a genetic form of epilepsy - Adults

People with Unverricht-Lundborg Disease (ULD), a genetic form of epilepsy are asked to participate in a research study being conducted by New York University Medical Center Comprehensive Epilepsy Center

You may be eligible to participate in this study if you:

• Are at least 18 years of age
• Have been diagnosed with ULD and proven by genetic testing
• Participated in the NO1125 protocol study

You may not participate in this study if you:

• Are currently taking the following medications: Felbamate, Phenytoin, Vigabatrine or any drug with possible central nervous system effects
• Have a history of suicide attempt during the last 5 years
• Are pregnant, breastfeeding, or intend to become pregnant during the study
• Have participated in another research study within the last 30 days

For more information,

If you would like to learn more about participating in this study, please send an e-mail message using the form below.